Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

olokizumab × Lymphoid × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Lymphoma, Follicular 1 Arthritis, Rheumatoid 1

Interventions

Rituximab 1395 Cyclophosphamide 1301 Vincristine 667 Doxorubicin 585 Etoposide 528 Prednisone 510 Cytarabine 485 fludarabine 464 Methotrexate 445 Dexamethasone 411 fludarabine phosphate 399 Lenalidomide 354 Filgrastim 343 Bendamustine Hydrochloride 280 Radiotherapy 265 venetoclax 258 ibrutinib 258 obinutuzumab 235 Peripheral Blood Stem Cell Transplantation 234 Melphalan 230 Granulocyte Colony-Stimulating Factor 214 Bortezomib 204 Gemcitabine 200 Whole-Body Irradiation 186 Busulfan 186 Mycophenolic Acid 174 Tacrolimus 164 Specimen Handling 156 Magnetic Resonance Spectroscopy 150 Calcium Dobesilate 150

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03120949 2023-10-12

CREDO 4

R-Pharm

Phase 3 Completed

2,106 enrolled 30 charts

Arthritis, Rheumatoid, Lymphoma, Follicular

Data powered by HemOnc (CC BY 4.0) Colophon ⚡